Literature DB >> 1972553

Multiple sclerosis or HTLV-I myelitis?

C M Poser1, G C Roman, J C Vernant.   

Abstract

Several authors have demonstrated the presence of antibodies against the HTLV-I retrovirus in patients with MS. Considerable controversy exists regarding the etiologic significance, if any, of this finding, but the presence of these antibodies in the blood or CSF of MS patients has led to reconsideration of that diagnosis in certain cases. It is recommended that, before the diagnosis of MS is changed to that of HTLV-I-associated chronic myelitis, at least 2 of the following abnormalities be present: (1) clinical or electrophysiologic involvement of peripheral nerve or muscle; (2) the presence of oligoclonal bands in the serum; (3) the presence in blood or CSF of lymphocytes with multilobed nuclei; (4) a positive serologic test for syphilis; (5) the presence of a sicca syndrome; and (6) the presence of pulmonary lymphocytic alveolitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972553     DOI: 10.1212/wnl.40.7.1020

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Multiple sclerosis, tropical spastic paraparesis and HTLV-I infection.

Authors:  R F Gledhill; P H Dessein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-06       Impact factor: 10.154

2.  Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.

Authors:  F Alcindor; R Valderrama; M Canavaggio; H Lee; A Katz; C Montesinos; R E Madrid; R R Merino; P A Pipia
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  Differential diagnosis of HTLV-I-associated myelopathy and multiple sclerosis in Iranian patients.

Authors:  B Kitze; R W Turner; M Burchhardt; S Poser; G Hunsmann; T Weber
Journal:  Clin Investig       Date:  1992-11

4.  Human retrovirus and multiple sclerosis.

Authors:  J P Antel; N R Cashman
Journal:  Mayo Clin Proc       Date:  1991-07       Impact factor: 7.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.